Ritonavir Increases levels of Schering HCV Protease Inhibitor SCH503034
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients. | Semantic Scholar
Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing's syndrome - S Noe, H Jaeger, S Heldwein, 2018
Ritonavir (Norvir)
Ritonavir - Wikipedia
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Boosted protease inhibitor and lamivudine provides effective maintenance treatment | aidsmap
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial - The Lancet HIV
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins - ScienceDirect
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression - ScienceDirect
Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
How Ritonavir acts as booster drug - YouTube
Lopinavir/ritonavir - Wikipedia
Ritonavir (Norvir) - Indications, Dose, Side effects
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Switch to RPV-TDF-FTC from Ritonavir-boosted PI Regimen SPIRIT STUDY - ppt download
Trial profile. DTG, dolutegravir; PI/r, ritonavir-boosted protease... | Download Scientific Diagram
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir ... | GrepMed
What Is Lopinavir and Ritonavir Combination Therapy?
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers | SpringerLink
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
